Suppr超能文献

探讨预测支气管肺发育不良的临床、超声心动图和分子生物标志物。

Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.

机构信息

Pediatric Cardiology Department, Ramón y Cajal University Hospital, Madrid, Spain.

Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain.

出版信息

PLoS One. 2019 Mar 6;14(3):e0213210. doi: 10.1371/journal.pone.0213210. eCollection 2019.

Abstract

INTRODUCTION

Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in childhood, related to prematurity, and the most common cause of pulmonary hypertension (PH) secondary to pulmonary disease in children. Moderate and severe BPD have a worse outcome and relate more frequently with PH. The prediction of moderate or severe BPD development in extremely premature newborns is vital to implement preventive strategies. Starting with the hypothesis that molecular biomarkers were better than clinical and echocardiographic factors, this study aims to explore the ability of clinical, echocardiographic and analytical variables to predict moderate or severe BPD in a cohort of extremely preterm infants.

PATIENTS AND METHODS

We designed a prospective longitudinal study, in which we followed a cohort of preterm newborns (gestational age <28 weeks and weight ≤ 1250 grams). In these newborns we recorded weekly clinical and echocardiographic variables as well as blood and tracheal aspirate samples, to analyze molecular biomarkers (IL-6, IL-1, IP10, uric acid, HGF, endothelin-1, VEGF, CCL5). Variables and samples were collected since birth up to week 36 (postmenstrual age), time-point at which the diagnosis of BPD is established.

RESULTS

We included 50 patients with a median gestational age of 26 weeks (IQR 25-27) and weight of 871 g (SD 161,0) (range 590-1200g). Three patients were excluded due to an early death. Thirty-five patients (74.5%) developed BPD (mild n = 14, moderate n = 15, severe n = 6). We performed a logistic regression in order to identify risk factors for moderate or severe BPD. We compared two predictive models, one with two variables (mechanical ventilation and inter-ventricular septum flattening), and another-one with an additional molecular biomarker (ET-1).

CONCLUSIONS

The combination of clinical and echocardiographic variables is a valuable tool for determining the risk of BPD. We find the two variable model (mechanical ventilation and echocardiographic signs of PH) more practical for clinical and research purposes. Future research on BPD prediction should be oriented to explore the potential role of ET-1.

摘要

简介

支气管肺发育不良(BPD)是儿童中最常见的慢性肺部疾病,与早产有关,也是儿童肺部疾病相关肺动脉高压(PH)最常见的原因。中重度 BPD 预后较差,与 PH 关系更密切。预测极早产儿中中重度 BPD 的发生对于实施预防策略至关重要。本研究从分子生物标志物优于临床和超声心动图因素的假设出发,旨在探讨临床、超声心动图和分析变量预测极早产儿中、重度 BPD 的能力。

患者和方法

我们设计了一项前瞻性纵向研究,对一组早产儿(胎龄<28 周,体重≤1250 克)进行了随访。在这些新生儿中,我们每周记录临床和超声心动图变量,以及血液和气管抽吸样本,以分析分子生物标志物(IL-6、IL-1、IP10、尿酸、HGF、内皮素-1、VEGF、CCL5)。从出生到 36 周(校正胎龄),即 BPD 诊断时间点,收集变量和样本。

结果

我们纳入了 50 名患者,中位胎龄为 26 周(IQR 25-27),体重为 871 克(SD 161.0)(范围 590-1200 克)。有 3 名患者因早期死亡而被排除在外。35 名患者(74.5%)发生 BPD(轻度 14 名,中度 15 名,重度 6 名)。我们进行了逻辑回归分析,以确定中重度 BPD 的危险因素。我们比较了两种预测模型,一种有两个变量(机械通气和室间隔平坦),另一种有一个额外的分子生物标志物(ET-1)。

结论

临床和超声心动图变量的组合是确定 BPD 风险的有用工具。我们发现,对于临床和研究目的,两变量模型(机械通气和超声心动图 PH 征象)更实用。未来对 BPD 预测的研究应侧重于探索 ET-1 的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7809/6402695/30a06550680e/pone.0213210.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验